Stocks
Novartis (NVS) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 70.3% | 33.8% | 39.1% | 40.1% | 41.9% | 40.0% | ||
| Changes by years, y/y, % | +36pp | -37pp | +5pp | +1pp | +2pp | +4.0% | |||
Novartis. EBITDA margin, %
Novartis. EBITDA margin, changes, pp
Novartis (NVS) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 42.8% | 41.0% | 40.7% | 38.0% | 40.0% | 40.0% | |
| Changes by years, y/y, % | +4pp | +0pp | -2pp | 0pp | -3pp | |||
| Changes by quarters, q/q, % | +5pp | -2pp | 0pp | -3pp | +2pp | |||
